Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Aflac commemorates National Childhood Cancer and Sickle Cell Disease Awareness Month


News provided by

Aflac

Sep 09, 2026, 08:45 ET

Share this article

Share toX

Share this article

Share toX

Company's 30-plus-year commitment results in major milestone, surpassing $200 million in contributions for treatment and research

COLUMBUS, Ga., Sept. 9, 2026 /PRNewswire/ -- Aflac, a leading provider of supplemental health insurance and long-term supporter of families facing childhood cancer and blood disorders, is honoring National Childhood Cancer and Sickle Cell Disease Awareness Month by announcing that the company has surpassed the $200 million level of contributions to this cause. Primary supporter of the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Aflac, its employees and its independent sales agents have been donating to the Center since 1995.

Continue Reading
On Sept. 5, during National Childhood Cancer and Sickle Cell Disease Awareness Month, patients, families and staff from the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta were honored at the Aflac Kickoff Game in Atlanta. Aflac recently surpassed $200 million in donations to help families facing childhood cancer and blood disorders.
On Sept. 5, during National Childhood Cancer and Sickle Cell Disease Awareness Month, patients, families and staff from the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta were honored at the Aflac Kickoff Game in Atlanta. Aflac recently surpassed $200 million in donations to help families facing childhood cancer and blood disorders.

"Aflac's more than three-decade relationship with the Aflac Cancer and Blood Disorders Center has resulted in many incredible achievements, including the center's evolution into one of the nation's most advanced childhood cancer and sickle cell centers in America," Aflac Chairman and CEO Dan Amos said. "I could not be prouder of our company, our employees and our independent sales agents, who have contributed more than $131 million from their commission checks over the years. As a company whose mission is to help people when they need us most, I cannot think of a more appropriate cause than to help children cope with these terrible diseases."

To commemorate this milestone, the company has produced a video focusing on how childhood cancer treatment has evolved over the past 30 years, resulting in a current five-year survival rate of 85 percent.1 The video will appear on local television stations across the nation as well as on Aflac's social media channels.

As part of the activities around National Childhood Cancer and Sickle Cell Disease Awareness Month, Aflac sponsored the Aflac Kickoff Game that aired Sept. 5 on the ABC Network, signaling the start of the 2026 college football season. Now in its fourth year, the Aflac Kickoff Game's Kickoff for a Cause philanthropic initiative has generated more than $1.2 million to support children and families in the community. This year's theme, "More Than a Name, More Than a Game," demonstrated how Aflac's commitment extends beyond its name through its support of patients and caregivers at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta. As part of celebrating more than $200 million in contributions to the Center since 1995, Aflac hosted 200 current and former patients, family members and staff at the game between the Auburn University Tigers and the Baylor Bears at Mercedes-Benz Stadium and recognized them during the game with special in-stadium honors.

"The impact of the $200 million milestone for Aflac cannot be overstated for the children and families at the Aflac Cancer and Blood Disorders Center," said Shari Barkin, MD, MSHS, Pediatrician-in-Chief at Children's Healthcare of Atlanta and Chair of the Department of Pediatrics at Emory University. "Aflac has been an incredible partner for more than three decades, helping us to advance the treatment we provide our patients. Thanks in part to their incredible support, the Aflac Cancer and Blood Disorders Center is one of the leading pediatric cancer and blood disorders programs in the country, caring for more than 500 new cancer patients and more than 5,000 children with sickle cell disease, hemophilia and other blood disorders annually."

In keeping with its mission of support to pediatric cancer and blood disorders patients and siblings, the Aflac Childhood Cancer Foundation awarded 12 grants to Child Life programs across the country this month. Child Life programs help children and families cope with the emotional, developmental and psychological challenges of cancer treatment and hospitalization. In pediatric cancer centers, Child Life specialists help ensure that children can continue to learn, play, express emotions and maintain a sense of normalcy during intensive medical care. Ninety-five grants totaling $176,500 have been awarded since 2019.

This year's recipients are James and Connie Maynard Children's Hospital; WVU Medicine; Children's Miracle Network at KU Medical Center; Whip Pediatric Cancer; Seattle Children's Hospital; Phoenix Children's Hospital; Mayo Clinic Children's Hospital; Children's of Alabama; Good Samaritan University Hospital; Dell Children's Medical Center; Rady Children's Health of Orange County; and Upstate Golisano Children's Hospital.

September also marks the 10th anniversary of the Aflac Childhood Cancer Foundation's $6.2 million partnership with Children's Miracle Network, a nonprofit organization that raises funds for 170 children's hospitals across the United States and Canada, many of which have assisted in the distribution of My Special Aflac Duck® to children facing cancer and sickle cell disease. The award-winning robotic companion is designed to address psychosocial needs of pediatric patients by helping with communication, understanding treatment through medical play, and providing comfort and distraction through art, music and more. Nearly 50,000 children ages 3 and up across the U.S., Japan and Northern Ireland have received the cuddly companion free of charge since 2018.

ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.2 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force.3 The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 20 consecutive years (2026) and Fortune's World's Most Admired Companies for 25 years (2026). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/español. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under "Sustainability."

Frequently Asked Questions
Q: What does Aflac's $200 million milestone represent?
A: The milestone reflects more than three decades of support from Aflac, its employees and its independent sales agents for childhood cancer and blood disorder treatment, research, patient care and family support programs. Since 1995, these contributions have helped advance the work of the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and support initiatives benefiting pediatric patients and their families across the country.

Q: How does Aflac support children with cancer and sickle cell disease beyond financial contributions?
A: In addition to funding treatment, research and patient support programs, Aflac helps improve the patient experience through initiatives such as My Special Aflac Duck®, a robotic companion designed to provide comfort, encourage communication and support medical play for children facing cancer and sickle cell disease. Aflac also supports awareness campaigns, family-centered events, Child Life programs and partnerships with organizations such as Children's Miracle Network hospitals to help children and families throughout their treatment journey.

Q: Why does Aflac focus on childhood cancer and sickle cell disease?
A: Childhood cancer and sickle cell disease can have life-changing physical, emotional and financial impacts on children and their families. For decades, supporting these patients has been central to Aflac's commitment to helping people when they need it most. Through investments in treatment, research, Child Life programs, patient support initiatives and innovations such as My Special Aflac Duck®, Aflac works to improve outcomes and quality of life for children facing these serious illnesses while supporting the families who care for them.

1 Childhood Cancer | American Cancer Society ; Childhood Cancer Key Statistics | American Cancer Society, accessed August 31, 2026
2 LIMRA 2025 U.S. Supplemental Health Insurance Total Market Report
3 As of March 31, 2025, Aflac estimates based on company data

Media contact: Jon Sullivan, 706-763-4813 or [email protected]

Analyst and investor contact: David A. Young, 706-596-3264, 800-235-2667 or [email protected]

Aflac | Aflac New York | WWHQ | 1932 Wynnton Road | Columbus, GA 31999

SOURCE Aflac

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Affleck and Aflac. It was only a matter of time.

Affleck and Aflac. It was only a matter of time.

Two famous names have long been blurred together in pop culture: Aflac and Affleck. Today, the coincidence gets an official title card as Aflac, the...

Aflac along with renowned educator Ron Clark and DonorsChoose embark on project to teach children social-emotional skills

Aflac along with renowned educator Ron Clark and DonorsChoose embark on project to teach children social-emotional skills

As an extension of Aflac's long-term commitment to children and families facing cancer and blood disorders, the company today announced a new...

More Releases From This Source

Explore

Health Insurance

Health Insurance

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Insurance

Insurance

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.